Sort by
Search results
FIBRIPHEN 1
Measurement of fibrinogen in plasma. Detection of low fibrinogen concentrations. Detection of elevated fibrinogen concentrations (> 4g/L): In clinical situations associated with inflammation Risk factor for cardiovascular disease and thrombosis Hypofibrinogenemia, mainly associated with severe liver disease, and excessive consumption of fibrinogen (DIC, hyperfibrinolysis). Numerous variants of fibrinogen described, associated to asymptomatic cases, or to cases with bleeding and/or thrombosis.
Dabigatran (Pradaxa®) Control Plasma (low range)
Quality control titrated and optimized for anti-IIa colorimetric assays (HEMOCLOT Thrombin Inhibitors: ref. CK002K/CK002L).
Dabigatran (Pradaxa®) Control Plasma
Quality control titrated and optimized for anti-IIa colorimetric assays (HEMOCLOT Thrombin Inhibitors: ref. CK002K/CK002L).
HEMOCLOT Thrombin Time 8 (Conventional/bovine Thrombin)
Conventional thrombin time, highly sensitive to heparins and thrombin inhibitors.
HEMOCLOT Thrombin Time 2 (Conventional/bovine Thrombin)
Conventional thrombin time, highly sensitive to heparins and thrombin inhibitors.
HEMOCLOT VII-X
Vitamin K deficiency. Vitamin K antagonists. Isolated factor VII or X deficiency. Accelerated clotting factor consumption (DIC).
BIOPHEN CS-61(44)
Chromogenic substrate for urokinase.
BIOPHEN CS-05(88)
Chromogenic substrate for tPA.
BIOPHEN CS-01(38)
Chromogenic substrate for thrombin.
BIOPHEN CS-41(03)
Chromogenic substrate for plasmin and plasminogen – SK.